Bryxta 300 Injection 12 ml
₹23775.9*
MRP ₹28995
18% off
₹24646*
MRP ₹28995
15% CB
₹4349 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Bryxta 300 Injection 12 ml is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Cancer can start in one region of the body and spread to other parts. This is referred to as metastasis.
Bryxta 300 Injection 12 ml contains 'Bevacizumab' that works against vascular endothelial growth factor (VEGF) which is found on the lining of lymph and blood vessels. VEGF causes blood vessels to grow within tumours which provide oxygen and nutrients to the tumour. Inhibition of vascular endothelial growth factor limits the flow of oxygen and nutrients to the tumour, causing it to shrink or cease developing. Thus, it helps treat cancers.
Bryxta 300 Injection 12 ml will be administered by a healthcare professional; do not self-administer. Based on your medical condition, your doctor will decide the dose and duration. In some cases, Bryxta 300 Injection 12 ml may cause loss of appetite, constipation, fever, nosebleeds, change in speech, and taste. The majority of these side effects do not require medical treatment and fade away with time. However, consult your doctor if the side effects persist or worsen
Avoid taking Bryxta 300 Injection 12 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Bryxta 300 Injection 12 ml may cause sleepiness and fainting, so avoid driving while on treatment with Bryxta 300 Injection 12 ml. Do not breastfeed during the treatment and for 6months after the last dose of Bryxta 300 Injection 12 ml. Keep your doctor informed about your health condition and all the medicines you take to rule out any side effects.
Bryxta 300 Injection 12 ml contains Bevacizumab, a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Bryxta 300 Injection 12 ml works against a protein called vascular endothelial growth factor (VEGF). Vascular endothelial growth factor (VEGF) inhibition limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thus, it helps treat cancer.
Bryxta 300 Injection 12 ml should only be taken under medical supervision. While taking Bryxta 300 Injection 12 ml, the doctor will monitor your condition on a regular basis. If you have a history of allergic reactions to Bryxta 300 Injection 12 ml or other medications, inform your doctor before taking it. Avoid taking Bryxta 300 Injection 12 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Bryxta 300 Injection 12 ml may cause sleepiness and fainting, so avoid driving while on treatment with Bryxta 300 Injection 12 ml. Inform your doctor if you have/had high blood pressure, heart attack, stroke, bleeding problems, stomach/intestinal bleeding, perforation; if you had surgery in the past 28days/are due to have surgery. Do not breastfeed during the treatment and for 6months after the last dose of Bryxta 300 Injection 12 ml. While taking Bryxta 300 Injection 12 ml, please do not get any immunizations or vaccinations unless your doctor has approved it. Bryxta 300 Injection 12 ml may increase the risk of bleeding, so be cautious and consult your doctor if you notice any bleeding or bruising.
Drug-Drug Interactions: Bryxta 300 Injection 12 ml may have interaction with a drug used to treat renal and gastrointestinal cancer (sunitinib) and platinum or taxane-based therapies for lung or metastatic breast cancer. Inform your doctor if you have recently received, or are receiving, radiotherapy.
Drug-Food Interactions: Avoid the consumption of alcohol while taking Bryxta 300 Injection 12 ml.
Drug-Disease Interactions: Inform your doctor if you have/had infections, bleeding disorders, fistula formation (an abnormal connection between two body parts), GI perforation, hypertension, PRES (Posterior Reversible Encephalopathy Syndrome), proteinuria (abnormal quantities of protein in the urine), and thromboembolic disorders.
Cancer: It is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs. Cancer sometimes begins in one part of the body and spreads to other areas. It occurs due to mutations in genes that regulate cell growth. The mutations cause the cells to divide and multiply in an uncontrolled manner, leading to tumour formation. The most common cancer treatment methods are surgery, chemotherapy, radiotherapy, bone marrow (stem cell) transplantation, immunotherapy, and targeted drug therapy.
Country of origin
Keep Refrigerated. Do not freeze.Prepaid payment required.
Alcohol
Unsafe
You are recommended to avoid alcohol consumption while taking Bryxta 300 Injection 12 ml. It could lead to unpleasant side effects.
Pregnancy
Unsafe
Bryxta 300 Injection 12 ml should not be used during pregnancy because it causes harm to the fetus. Women of childbearing potential must use an effective contraception method while taking Bryxta 300 Injection 12 ml and at least six months after the last dose. Please consult your doctor about any concerns regarding this.
Breast Feeding
Unsafe
Avoid breastfeeding during treatment and for 6months after the last dose. This is due to the possibility of the medication being passed on to the infant through breast milk.
Driving
Caution
Caution should be exercised when driving or operating machinery because in some cases, Bryxta 300 Injection 12 ml may cause sleepiness and fainting.
Liver
Caution
If you have/had a history of any liver-related diseases, please inform the doctor before taking Bryxta 300 Injection 12 ml. Your doctor will weigh the benefits and potential risks before prescribing Bryxta 300 Injection 12 ml.
Kidney
Caution
If you have/had a history of any kidney-related diseases, please inform the doctor before taking Bryxta 300 Injection 12 ml. Your doctor will weigh the benefits and potential risks before prescribing Bryxta 300 Injection 12 ml.
Children
Unsafe
Bryxta 300 Injection 12 ml is not recommended for children below 18years as the safety and effectiveness have not been established.
Product Substitutes
We provide you with authentic, trustworthy and relevant information